17 hours BioAge Labs: Weighing The Risks And Rewards Of A Biotech Revival Seeking Alpha BioAge Labs: Weighing The Risks And Rewards Of A Biotech Revival. Biotech
1 day Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative BiotechInsider Monkey
1 day Cubist Systematic Strategies LLC Purchases Shares of 59,163 Legend Biotech Co. (NASDAQ:LEGN)MarketBeat
2 days Systematic Financial Management LP Has $30.99 Million Holdings in Innoviva, Inc. (NASDAQ:INVA)MarketBeat
4 days Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%Investor's Business Daily
5 days Hedge Fund and Insider Trading News: Chris Hansen, David Tepper, Paul Singer, Steven Cohen, Platinum Asset Management, Elliott Investment Management, Millennium Management, Fortress Biotech Inc (FBIO), Crowdstrike Holdings Inc (CRWD), and MoreInsider Monkey
5 days Novo Nordisk’s $600 Million Gambit Could Be a Game Changer for the Stock. Here’s Why.The Motley Fool
5 days A surfer without a degree is worth $16 billion after his biotech company’s stock soared 1,100% in a yearBusiness Insider
7 days Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trialMarketWatch
1 week Tesla Leads S&P 500 Index, While Biotech Giant Tumbles On Court RulingInvestor's Business Daily
2 weeks GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA AnalyticsInvestor's Business Daily
2 weeks Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?The Motley Fool
2 weeks Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation ExpansionSeeking Alpha
2 weeks How BioNTech, Up 26% Over Four Days, Is Riding Summit’s Coattails To A RecoveryInvestor's Business Daily
2 weeks Nuvalent Flies On ‘Multibillion-Dollar’ Potential, While Iteos Crashes On Patient DeathsInvestor's Business Daily
2 weeks Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?The Motley Fool
2 weeks Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.The Motley Fool
2 weeks Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You’ll Win MoreThe Motley Fool
3 weeks Gilead Sciences Pops On A New $4 Billion Opportunity In HIV PreventionInvestor's Business Daily
3 weeks The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart MonopolyThe Wall Street Journal
3 weeks Terns Pharmaceuticals’ stock soars 17% after biotech posts positive results in trial of weight-loss drug in pill formMarketWatch
3 weeks Summit Therapeutics’ stock pops as lung-cancer treatment beats Merck blockbuster in late-stage trialMarketWatch
3 weeks Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?Insider Monkey
3 weeks Regeneron Pharmaceuticals, Inc. (REGN): The Best Biotech Stock According to Hedge Funds?Insider Monkey
3 weeks Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?Insider Monkey
3 weeks Is Cytokinetics, Incorporated (CYTK) a Good Biotech Stock According to Hedge Funds?Insider Monkey
3 weeks Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock NowInsider Monkey
3 weeks Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock?Insider Monkey
4 weeks Travere Stock Pops After Snagging Full Approval For Calliditas Rival In Kidney DiseaseInvestor's Business Daily
4 weeks Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?The Motley Fool
4 weeks Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the YearYahoo Finance
4 weeks Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive MarketInvestor's Business Daily
1 month Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpoxMarketWatch